Cost-utility analysis: current methodological issues and future perspectives
about
A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?Cost-effectiveness analysis of pharmaceutical treatment options in the first-line management of major depressive disorder in Belgium.The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson's disease
P2860
Cost-utility analysis: current methodological issues and future perspectives
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cost-utility analysis: current methodological issues and future perspectives
@ast
Cost-utility analysis: current methodological issues and future perspectives
@en
type
label
Cost-utility analysis: current methodological issues and future perspectives
@ast
Cost-utility analysis: current methodological issues and future perspectives
@en
prefLabel
Cost-utility analysis: current methodological issues and future perspectives
@ast
Cost-utility analysis: current methodological issues and future perspectives
@en
P2860
P356
P1476
Cost-utility analysis: current methodological issues and future perspectives
@en
P2093
Dominique J Dubois
Mark J C Nuijten
P2860
P356
10.3389/FPHAR.2011.00029
P577
2011-06-08T00:00:00Z